equine herpes virus

Arqana has moved to allay concerns ahead of its Breeding Stock Sale following a reported outbreak of Equine Herpes Virus (EHV-1) in two sport horses near Paris.  A statement released by the sales company on Tuesday read, "With just a few days to go before the Vente d'Elevage, Arqana has sent all vendors a specific equine health protocol to follow as a result of a call for vigilance by the RESPE (equine infectious disease surveillance) after two cases of EHV-1 were reported in mid-November in sport horses located in the...

Edited press release Grayson-Jockey Club Research Foundation has issued a formal call for research applications focused on the development of a nucleic acid-based vaccine against equine herpes virus (EHV). Dr. John Ballantyne and Fargo-Moorhead Area Foundation have committed $2 million to fund this research. "We are so grateful to Dr. Ballantyne for his generosity in supporting efforts to address EHV, a disease that affects all horses," said Dell Hancock, chair of the foundation. "This gift will enable Grayson to continue its commitment to funding critical research for horses, and our...